NEOSEQ Trademark Information

Trademark by NeoGenomics Laboratories, Inc.

Medical and scientific research information in the field of human disease and human medical conditions; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinic...

Medical diagnostic testing services in the field of human disease and human medical conditions; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; medical information; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment pu...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: NEOSEQ
Status/Status Date:
THIRD EXTENSION - GRANTED
10/13/2021
Serial Number: 88064205
Filing Date: 8/3/2018
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Medical and scientific research information in the field of human disease and human medical conditions; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services; providing information, interactive information, and reports to others in the field of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing information to others in the field of scientific testing and research and clinical scientific testing; providing an internet website portal featuring information in the field of scientific testing and research, medical research, and clinical scientific testing; providing cloud-based information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; providing online non-downloadable Internet-based software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; software as a service (SAAS) services featuring software for medical testing and analysis of medical test results; software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; genetic mapping for scientific purposes, namely, gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 2/18/2020
Last Applicant/Owner:
NeoGenomics Laboratories, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
THIRD EXTENSION - GRANTED
10/13/2021
Correspondent Search:
JENNIFER L. WHITELAW is a correspondent of NEOSEQ trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on